Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

A new way to grow T cells in the lab enables them to live longer and better destroy cancer cells in a mouse model of melanoma ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

The drug in question, called firicabtagene autoleucel or firi-cel, is an autologous CD22 CAR-T cell therapy that had been ...

Yescarta continued to demonstrate durable responses after a median follow-up of more than five years in patients with R/R ...